| Value | ₹10.31 Cr |
|---|
BSE filing, NSE: EQUITASBNK. Summary written from the filing by ALFA Finder's alert engine.
Equitas Small Finance Bank Ltd: key numbers
- Share price
- ₹57.17
- Market cap
- ₹6,541 Cr
- Revenue (annual)
- ₹6,794 Cr
- Net profit (annual)
- ₹116.0 Cr
- P/E (TTM)
- 12.8×Sector 19.1×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 15.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Equitas Small Finance Bank Ltd
All →Equitas Small Finance Bank Earnings Call Transcript: Key Takeaways
Bank crosses ₹1 lakh crore business milestone despite MD P.N. Vasudevan's surprise resignation over family investment conflicts.
Equitas Small Finance Bank Investor Presentation: Key Takeaways
Q2FY27 record PAT Rs218 Cr (vs Rs24 Cr); RoA 1.31%, RoE 13.50%; advances up 30% YoY to Rs50,669 Cr; NIM compressed to 6.69% on surplus liquidity.
Equitas Small Finance Bank Results Update
Equitas Small Finance Bank posted Q2FY27 PAT of ₹218 crore, up 803% YoY. Total business crossed ₹1 lakh crore with advances and deposits each surpassing ₹50,000 crore.
Equitas Small Finance Bank Management Change
Equitas Small Finance Bank's MD & CEO P. N. Vasudevan resigned effective upon successor appointment. The Board will recommend suitable candidates subject to RBI approval.
Equitas Small Finance Bank Q2 FY27 Results: Net Profit ₹218 Cr, Up 804.6% YoY
Equitas Small Finance Bank Ltd reported revenue from operations of ₹2,066 Cr (+27.7% YoY) and net profit of ₹218 Cr (+804.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹218 Cr · +804.6% YoY
Equitas Small Finance Bank Other Announcement
The company submitted its quarterly shareholding pattern for the period ending September 30, 2026. This is a periodic regulatory compliance filing required under SEBI listing regulations.
Other financial results announcements
All →Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.1 Cr · +92.9% YoY
STL Networks Q2 FY27 Results: Net Loss of ₹16.1 Cr, Loss Narrows
STL Networks Ltd reported revenue from operations of ₹270.1 Cr (+17.0% YoY) and a net loss of ₹16.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹16.1 Cr
RPG Life Sciences Q2 FY27 Results: Net Profit ₹28.2 Cr, Down 23.6% YoY
RPG Life Sciences Ltd reported revenue from operations of ₹211.6 Cr (+16.5% YoY) and net profit of ₹28.2 Cr (-23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹28.2 Cr · -23.6% YoY
Alldigi Tech Q2 FY27 Results: Net Profit ₹26.6 Cr, Up 51.1% YoY
Alldigi Tech Ltd reported revenue from operations of ₹153.3 Cr (+4.0% YoY) and net profit of ₹26.6 Cr (+51.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.6 Cr · +51.1% YoY
Krishna Defence and Allied Industries Q2 FY27 Results: Net Profit ₹1,532 Cr, Up 71.8% YoY
Krishna Defence and Allied Industries Ltd reported revenue from operations of ₹7,529 Cr (+55.7% YoY) and net profit of ₹1,532 Cr (+71.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,532 Cr · +71.8% YoY
Bandaram Pharma Packtech Q2 FY27 Results: Net Profit ₹0.2 Cr, Up 100.0% YoY
Bandaram Pharma Packtech reported audited standalone and consolidated results for the quarter and half-year ended 30.09.2026. Consolidated revenue from operations for the half-year was Rs 4,540.28 lakhs.
- Key figure
- Net profit ₹0.2 Cr · +100.0% YoY